← All guides

Neuralink in 2026: 21 Trial Participants, VOICE Study & Blindsight

Written by AI from the sources linked. — How we work

Neuralink’s clinical progress in 2026: N1 & R1 hardware, 21 enrolled participants, intact-dura surgery, the VOICE speech demo, and Blindsight’s trial status.

Updated: · 4 min read

In this guide
  1. N1 implant, R1 surgical robot, and active trials
  2. Clinical milestones documented in 2026
  3. Research results vs. Blindsight approval status

Throughout 2026 Neuralink expanded clinical testing of its N1 brain-computer interface beyond basic cursor control into intact-dura insertion and thought-to-speech research, while the Blindsight vision implant remained pending regulatory clearance.

N1 implant, R1 surgical robot, and active trials

The wireless N1 (Telepathy) implant sits sealed in the skull with inductive charging and connects 1,024 electrodes across 64 ultra-thin flexible threads. The R1 surgical robot inserts those threads into the cortex while avoiding blood vessels on the brain surface. Established clinical programs include the PRIME study (computer and cursor control) and the CONVOY study (assistive robotic arm control).

Clinical milestones documented in 2026

Milestone Date Reported facts
Two-year Telepathy update Jan 28, 2026 21 participants enrolled worldwide (up from 3 in 2024), including 13 surgeries in H2 2025
First transdural procedure June 30, 2026 First clinical implant inserting threads through the intact dura mater without cutting the membrane
VOICE thought-to-speech Sept 2026 An ALS participant spoke a phrase in a voice rebuilt from old recordings; study holds FDA Breakthrough designation
Blindsight status As of Nov 2026 Stated by Musk on Oct 30 to be technically ready awaiting regulatory approval; no trial date set

Research results vs. Blindsight approval status

While the VOICE demonstration marked a visible step in decoding intended speech from neural activity, it remains a clinical research result rather than a commercial product. Likewise, although Musk posted on X on October 30, 2026 that Blindsight is technically ready, as of early November 2026 no Neuralink vision trial appeared on ClinicalTrials.gov and no date for a first human implant had been announced.

Review every milestone and source link on the Neuralink product page and in the glossary.

Comments

0

    Loading comments…

    No account needed. Links are blocked; IP hashes rotate daily in EU.